Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME) Study: a stepped-wedge cluster randomised controlled trial

Freeman, Christopher R., Scott, Ian A., Hemming, Karla, Connelly, Luke B., Kirkpatrick, Carl M., Coombes, Ian, Whitty, Jennifer ORCID: https://orcid.org/0000-0002-5886-1933, Martin, James, Cottrell, Neil, Sturman, Nancy, Russell, Grant M., Williams, Ian, Nicholson, Caroline, Kirsa, Sue and Foot, Holly (2021) Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME) Study: a stepped-wedge cluster randomised controlled trial. Medical Journal of Australia, 214 (5). pp. 212-217. ISSN 0025-729X

[thumbnail of Accepted_Manuscript]
Preview
PDF (Accepted_Manuscript) - Accepted Version
Download (827kB) | Preview

Abstract

Objective: To investigate whether integrating pharmacists into general practices reduces the number of unplanned re-admissions of patients recently discharged from hospital. Design, setting: Stepped wedge, cluster randomised trial in 14 general practices in southeast Queensland. Participants: Adults discharged from one of seven study hospitals during the seven days preceding recruitment (22 May 2017 ‒ 14 March 2018) and prescribed five or more long term medicines, or having a primary discharge diagnosis of congestive heart failure or exacerbation of chronic obstructive pulmonary disease. Intervention: Comprehensive face-to-face medicine management consultation with an integrated practice pharmacist within seven days of discharge, followed by a consultation with their general practitioner and further pharmacist consultations as needed. Major outcomes: Rates of unplanned, all-cause hospital re-admissions and emergency department (ED) presentations 12 months after hospital discharge; incremental net difference in overall costs. Results: By 12 months, there had been 282 re-admissions among 177 control patients (incidence rate [IR], 1.65 per person-year) and 136 among 129 intervention patients (IR, 1.09 per person-year; fully adjusted IR ratio [IRR], 0.79; 95% CI, 0.52‒1.18). ED presentation incidence (fully adjusted IRR, 0.46; 95% CI, 0.22‒0.94) and combined re-admission and ED presentation incidence (fully adjusted IRR, 0.69; 95% CI, 0.48‒0.99) were significantly lower for intervention patients. The estimated incremental net cost benefit of the intervention was $5072 per patient, with a benefit‒cost ratio of 31:1. Conclusion: A collaborative pharmacist‒GP model of post-hospital discharge medicines management can reduce the incidence of hospital re-admissions and ED presentations, achieving substantial cost savings to the health system. Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12616001627448 (prospective).

Item Type: Article
Uncontrolled Keywords: continuity of patient care,general practice,pharmacy,primary care,medicine(all) ,/dk/atira/pure/subjectarea/asjc/2700
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 21 Oct 2020 23:56
Last Modified: 22 Oct 2022 07:20
URI: https://ueaeprints.uea.ac.uk/id/eprint/77396
DOI: 10.5694/mja2.50942

Actions (login required)

View Item View Item